Novogene (688315.SS) Earnings Analysis
Novogene (688315.SS) has no confirmed upcoming earnings date. Trailing P/E 30.77.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688315.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 688315.SS. This page updates as the calendar is published.
688315.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-15 | 0.07 CNY | n/a | n/a | n/a |
| 2026-02-27 | 0.13 CNY | n/a | n/a | n/a |
| 2025-10-24 | 0.08431 CNY | n/a | n/a | n/a |
| 2025-04-14 | 0.08 CNY | n/a | n/a | n/a |
| 2025-02-26 | 0.1496 CNY | n/a | n/a | n/a |
| 2024-10-24 | 0.1389 CNY | n/a | n/a | n/a |
| 2024-08-14 | 0.1239 CNY | n/a | n/a | n/a |
688315.SS valuation and analyst view
| Trailing P/E | 30.77 |
|---|---|
| Trailing EPS | 0.37792 CNY |
| Price / book | 1.93 |
| Dividend yield | 0.37% |
| Market cap | 5.16B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Novogene (688315.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 688315.SS. This page updates as the calendar is published.
Did 688315.SS beat earnings last quarter?
Consensus estimate data was not available for 688315.SS's 2026-04-15 report.
What is 688315.SS's current P/E ratio and EPS?
688315.SS trades at a trailing P/E of 30.77 on trailing EPS of 0.37791825011134667 CNY.
What do analysts rate 688315.SS?
688315.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.